Notice of Special Interest (NOSI): Administrative Supplements for NIMH Grants to Expand Perinatal Mental Health Interventions and Services Research
Notice Number:

Key Dates

Release Date:

August 17, 2021

First Available Due Date:
April 01, 2022
Expiration Date:
April 02, 2022

Related Announcements

PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

Issued by

National Institute of Mental Health (NIMH)


This Notice of Special Interest (NOSI) informs current awardees that the National Institute of Mental Health (NIMH) is providing the opportunity to expand perinatal mental health research by funding administrative supplements to existing NIMH psychosocial prevention, treatment and mental health services intervention research grants or to conduct secondary analyses of pre-existing data sets pertaining to perinatal depression and other mood and anxiety disorders during the perinatal period. These administrative supplements will provide funds to augment existing non-perinatal trial samples by enrolling women during the perinatal period or to support new analyses of pre-existing data from mental health treatment, prevention or services intervention research involving women in the perinatal period. Research proposed in the supplement must fall within scope of the parent grant.

BACKGROUND: Perinatal mental illnesses comprise mental disorders that occur during pregnancy or following childbirth. Perinatal depression is one of the most common complications of pregnancy and the post-partum period; and pregnant people with mood disorders, including bipolar disorder, are at increased risk for suicide and post-partum psychosis. Anxiety disorders are also prevalent in the perinatal period and are often co-morbid with depression. Perinatal mental illnesses are prevalent and associated with negative sequelae for both mothers and infants. Well-studied psychosocial interventions can provide effective evidence-based treatment (EBT) options for pregnant and lactating people with commonly occurring mental disorders, including individuals who decline or discontinue standard-of-care pharmacologic interventions during pregnancy and lactation.

Established as part of the 21st Century Cures Act, The Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC), recommended inclusion and integration of pregnant and lactating women in the clinical research agenda. In January 2019, revisions to federal policy for the protection of human subjects were implemented, removing pregnant women as an explicit example of a “vulnerable population” requiring additional ethical scrutiny prior to participating in research.

RESEARCH OBJECTIVES: Arguments for adapting existing psychosocial interventions or testing novel psychosocial interventions specifically for perinatal women often lack empirical justification based on evidence of differential intervention outcomes between perinatal people and other people of childbearing age. Studies in response to this NOSI will help to build an evidence base to support an empirical understanding of similarities and differences between perinatal people and other people of childbearing age regarding mental health outcomes of preventive, treatment, or services interventions. Research supported by this NOSI should help to identify putative intervention mechanisms or drivers of differential outcomes between perinatal people and other people of childbearing age, thereby identifying targets for adapting or optimizing current interventions, or developing novel interventions in future studies. Lack of differential outcomes will also be informative. Intervention studies supported by the supplements should explore recruitment feasibility and the need for specialized safety assessment protocols for the inclusion of perinatal people in psychosocial intervention trials that are not specifically designed for perinatal people. A second objective is to collect data from across studies with the goal of generating sufficient sample sizes to allow comparisons of perinatal people to other people of childbearing age with respect to psychosocial intervention outcomes. This objective will be supported by sharing data and employing common data elements from current intervention trials or by analyzing existing data sets. NIMH will require data sharing in accordance with the Data Sharing Policy for the National Institute of Mental Health as described in NOT-MH-19-033 and strongly encourages applicants to use common data elements as described in NOT-MH-20-067. Measures should be selected to facilitate exploration of similarities and differences across perinatal and non-perinatal groups.

Description of circumstances for which administrative supplements are available.

Application and Submission Information

Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent.

  • PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

All instructions in the SF424 (R&R) Application Guide and PA-20-272 must be followed, with the following additions:

Budget: Applicants may request up to $250,000 Direct Costs but are limited to no more than the amount of the current parent budget.

  • Application Due Date(s) – NIMH will accept and review administrative supplement applications in response to this announcement on a continuous basis until April 1, 2022, by 5:00 PM local time of the applicant organization. All supplement applications must be received by April 1, 2022 and any applications submitted after that date will not be accepted.
  • For funding consideration, applicants must include “NOT-MH-21-215” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.
  • Requests may be for one year of support only.
  • The Research Strategy section of the application is limited to 6 pages.
  • Only existing awardees of active NIMH grant awards are eligible to apply. The parent award must be active when the supplement application is submitted (e.g., within the originally reviewed and approved project period), regardless of the time remaining on the current project.
  • Applicants are strongly encouraged to notify the program contact at the Institute supporting the parent award that a request has been submitted in response to this FOA in order to facilitate efficient processing of the request.
  • Applications nonresponsive to the terms of this NOSI will not be reviewed.
  • The proposed project for supplemental funding is required to be within the scope of the parent award.


Please direct all inquiries to:

Lauren D. Hill, PhD
National Institute of Mental Health (NIMH)
Telephone: 301-443-2638

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices